Medical Information

Quviviq should pay special attention to next day drowsiness, driving risks, and drug interactions. The following provides detailed medication precautions from these three aspects to ensure safety and efficacy.

Next day drowsiness management

Dali Leisheng may cause drowsiness the next day, especially during the early stages of medication or dosage adjustment. Patients should ensure at least 7 hours of sleep after taking medication to avoid worsening drowsiness symptoms due to insufficient sleep. Elderly people need to pay special attention to the risk of falling, and should sit and stand for a moment before moving when getting up.

(1) Protection for high-risk individuals

Elderly patients, those with liver dysfunction, and those who use central nervous system inhibitors in combination are more likely to experience daytime sleepiness. Patients of this type are advised to start with a low dose (25mg) and avoid engaging in activities that require high alertness.

(2) Symptom monitoring and response

If drowsiness persists for more than a week or affects daily life the next day, timely medical evaluation should be sought. When accompanied by attention deficit or muscle weakness, be alert to the possibility of drug overdose and adjust the dosage or discontinue medication if necessary.

2 Driving and high-risk activity restrictions

Dali Leisheng may impair driving ability and alertness when operating machinery. During the medication period, one should avoid dangerous activities such as driving or engaging in high-altitude work until the degree of impact of the medication on the individual is determined.

(1) Alcohol and sedatives are contraindicated

Do not use it in combination with alcohol or other central nervous system inhibitors (such as sleeping pills, anti anxiety drugs), otherwise it will have a sedative effect and significantly increase the risk of accidents.

(2) Special occupational requirements

Professional personnel who need to remain vigilant, such as drivers and machinery operators, should consult a doctor before taking medication and adjust working hours or suspend high-risk operations if necessary.

Key points of drug interactions

Dali Leisheng has significant interactions with CYP3A4 inhibitors or inducers. Strong CYP3A4 inhibitors (such as ketoconazole) are prohibited, while medium acting inhibitors (such as fluconazole) need to be reduced to 25mg.

(1) Risk of enzyme inducers

Strong CYP3A4 inducers (such as rifampicin) can reduce the blood concentration of Dali Lei, leading to a decrease in efficacy, and should be avoided in combination.

(2) Careful combination of drugs with narrow therapeutic window

Caution should be exercised when using CYP3A4 or P-gp substrates (such as digoxin) in combination, as it may increase the latter's blood drug concentration. If necessary, drug concentration should be monitored or dosage adjusted.